2-Amino-4-isobutyl-pyrimidin | 98427-09-9

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二嗪类
• 英文名称: 2-Amino-4-isobutyl-pyrimidin
• 英文别名: 4-isobutyl-pyrimidin-2-ylamine；4-(2-Methylpropyl)-2-pyrimidinamine；4-(2-methylpropyl)pyrimidin-2-amine
• CAS: 98427-09-9
• 化学式: C₈H₁₃N₃
• 分子量: 151.211
• InChiKey: OYLUXQLMIVJBKE-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.5
• 重原子数：
  11
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  51.8
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为产物：
  描述：

  碳酸胍 、 alkaline earth salt of/the/ methylsulfuric acid 生成 2-Amino-4-isobutyl-pyrimidin
  参考文献：
  名称：

  N¹-Sulfanilylamino-alkyl-pyrimidines

  摘要：

  DOI：

  10.1021/ja01262a034

文献信息

• Methods and compositions of novel triazine compounds
  申请人：Timmer T. Richard

  公开号：US20070099874A1

  公开（公告）日：2007-05-03

  The present invention relates to methods and compositions comprising compounds that treat pathophysiological conditions arising from inflammatory responses. In particular, the present invention is directed to compounds that inhibit or block glycated protein produced induction of the signaling-associated inflammatory response in endothelial cells. The present invention relates to compounds that inhibit smooth muscle proliferation. In particular, the present invention is directed to compounds that inhibit smooth muscle cell proliferation by modulating HSPGs such as Perlecan. The present invention further relates to the use of compounds to treat vascular occlusive conditions characterized by smooth muscle proliferation such as restenosis and atherosclerosis.

  本发明涉及用于治疗由炎症反应引起的病理生理状态的化合物的方法和组合物。特别地，本发明涉及抑制或阻断糖化蛋白诱导内皮细胞信号相关炎症反应的化合物。本发明涉及抑制平滑肌增殖的化合物。特别地，本发明涉及通过调节HSPG（如Perlecan）来抑制平滑肌细胞增殖的化合物。本发明进一步涉及使用化合物治疗由平滑肌增殖所特征的血管闭塞性疾病，例如再狭窄和动脉粥样硬化。
• MACROCYCLES, COBALT AND IRON COMPLEXES OF SAME, AND METHODS OF MAKING AND USING SAME
  申请人：The Research Foundation for The State University of New York

  公开号：US20160228581A1

  公开（公告）日：2016-08-11

  Provided are macrocyclic compounds and iron or cobalt coordinated macrocyclic compounds. The compounds can be used as MRI contrast agents. Certain compounds are redox active and can be used to assess the biological redox status of a sample.

  提供的是大环化合物以及铁或钴配位的大环化合物。这些化合物可以用作MRI对比剂。某些化合物是氧化还原活性的，可以用于评估样品的生物氧化还原状态。
• FLAP MODULATORS
  申请人：ECCLES Wendy

  公开号：US20150368270A1

  公开（公告）日：2015-12-24

  The present invention relates to compounds of Formula (I), or a form thereof wherein ring A, R 1 , L and R 2 are as defined herein, useful as FLAP modulators. The invention also relates to pharmaceutical compositions comprising compounds of Formula (I). Methods of making and using the compounds of Formula (I) are also within the scope of the invention.

  本发明涉及式(I)的化合物，或其形式，其中环A，R1，L和R2如本文所定义，用作FLAP调节剂。本发明还涉及包含式(I)化合物的制药组合物。制备和使用式(I)化合物的方法也在本发明的范围内。
• Macrocycles, cobalt and iron complexes of same, and methods of making and using same
  申请人：The Research Foundation for The State University of New York

  公开号：US10960088B2

  公开（公告）日：2021-03-30

  Provided are macrocyclic compounds and iron or cobalt coordinated macrocyclic compounds. The compounds can be used as MRI contrast agents. Certain compounds are redox active and can be used to assess the biological redox status of a sample.

  本文提供了大环化合物和铁或钴配位大环化合物。这些化合物可用作核磁共振成像造影剂。某些化合物具有氧化还原活性，可用于评估样本的生物氧化还原状态。
• US7169785B2
  申请人：——

  公开号：US7169785B2

  公开（公告）日：2007-01-30